9/30 Lipid Digestion and Absorption Flashcards
what are bile salts
modified cholesterol that emulsifies fat and activates digestion of TG. made in pancrease and released into duodenum. help increase the release of FAs
orlistat
weight loss drug that inhibits lipase action in the intestinal lumen, so you don’t end up digesting (and hence, absorbing) dietary fat
abetalipoproteinemia
AR inherited loss of MTP function, pts are missing chylomicrons, VLDL, and fat-soluable vitamins
same symptoms if loss of ApoB (familial hypobetalipoproteinemia)
CF: caloric deficit, night blindness, neural defects, RBCs with spikes (acanthocytes), spinal defects, steatorrhea
hyperchylomicronemia
loss of either LPL or ApoCII, results in a large increase in chylomicrons/TG in blood.
CF: milky pink blood
hypertriglyceridemia
high blood TG levels usually from VLDL
deposits of TG seen as eruptive xanthomas, at risk for acute pancreatitis
can lead to high levels of LDL and low levels of HDL
take a fibrate
fibrates
gemfibrozil/fenofibrate, lower TG in blood by inducing synthesis of LPL and apoproteins in HDL after activation of PPAR-a. increases FAs in blood
SEs: myopathy and gallstones
journey of a TG from mouth to liver
mouth, esophagus, stomach, small intestines, lacteal, lymphatic vessel, thoracic duct, venous system, liver
LPL
lipoprotein lipase, in blood, breaks down chylomicrons into FAs that will a) go into tissues, b) go into adipocytes, or c) remnants in blood (chylomicron remnants) will go to liver
expression is increased by insulin (and fibrate drugs)
activated by ApoCII
ApoB
critical for the synthesis of chylomicron in the enterocytes (ApoB-48) and VLDL in the liver (ApoB-100), peripheral protein on the lipoprotein
MTP
microsomal triglyceride transfer protein, required to make chylomicron in lumen of endoplasmic reticulum of enterocyte, puts TGs/cholesterol/fat-soluable vitamins into chylomicrons
ApoCII
aquisition causes maturation of nascent chylomicrons, comes from HDL in the blood, a peripheral apoprotein, needed to activate LPL (coenzyme)
ApoE
when LPL in blood breaks down chylomicrons, ApoCII is traded for ApoE w/ HDL. binds to chylomicron remnant receptors and also the liver receptors to initiate receptor-mediated endocytosis
ezetimibe
inhibits cholesterol uptake by enterocyte by inhibiting NPC1L1 transporter
HDL
high density lipoprotein, transfers cholesterol from tissues to the liver, prevents inappropriate accumulation of cholesterol
LDL
low density lipoprotein, derived from VLDL and IDL, delivers cholesterol to peripheral tissues